Compare Agilent Technologies Inc (A) vs Vanguard Mega Cap Growth ETF (MGK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agilent Technologies Inc vs Vanguard Mega Cap Growth ETF — how do they compare? Agilent Technologies Inc trades at $149.35 (market cap $42.00B), while Vanguard Mega Cap Growth ETF trades at $90.02. The key difference: Agilent Technologies Inc pays a 0.69% dividend while Vanguard Mega Cap Growth ETF pays none. Which is the better fit depends on your goals.
| A | MGK | |
|---|---|---|
Market Cap | $42.00B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $157.20 | $92.06 |
52-Week Low | $110.24 | $70.70 |
Enterprise Value | $43.55B | — |
Dividend Yield | 0.69% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
MGK, the Vanguard Mega Cap Growth ETF, trades at $90.79, up 0.87% on the day, with a bullish technical signal driven by strong moving average alignment. The ETF's concentrated portfolio of 69 large-cap U.S. growth stocks, heavily weighted toward technology and consumer discretionary sectors, has delivered robust historical returns. Recent news highlights its low 0.05% expense ratio and potential inclusion of high-profile stocks like SpaceX, reinforcing its appeal for growth-oriented investors seeking mega-cap exposure.
The outlook for MGK remains positive due to its focus on leading growth companies, but risks include high concentration in tech stocks and sensitivity to market volatility. Investors benefit from cost efficiency and historical outperformance, yet must monitor sector-specific downturns and valuation pressures. The ETF is suited for long-term growth strategies with tolerance for drawdowns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Vanguard Mega Cap Growth ETF
MGK is an ETF that seeks to track the performance of the CRSP US Mega Cap Growth Index. It provides a low-cost, diversified exposure to the largest growth companies in the U.S. stock market. The fund is composed of mega-cap stocks that exhibit key growth factors, including high expected long-term earnings growth, high historical sales and earnings growth, and high return on assets. MGK is typically used by investors seeking long-term capital appreciation from market-leading firms.
Read more on MGK →
